Investigational Vaccine to Prevent RSV in Older Patients Gets Breakthrough Status

The FDA has granted Breakthrough Therapy designation for their investigational prophylactic vaccine for the prevention of respiratory syncytial virus.

Investigational Vaccine to Prevent RSV in Older Patients Gets Breakthrough Status
QR Code
Embed the QR code on your website:
Download
Copy